Generation of human monoclonal antibodies to cancer-associated antigens using limited numbers of patient lymphocytes

Lloyd H Smith, A. Yin, M. Bieber, N. N H Teng

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

A limiting dilution method for the efficient transformation by Epstein-Barr virus (EBV) of human B lymphocytes has been applied to the production of human monoclonal antibodies to ovarian cancer-associated antigens. Limited numbers (e.g., 2 × 105) of EBV-infected B lymphocytes from ovarian cancer patient spleen, lymph node, tumor, ascites and blood were successfully transformed using this method. An immunofiltration assay system was employed to identify EBV transformants secreting IgM antibody which reacted selectively with ovarian cancer patient ascites tumor cells, but not with a mixture of normal cell types. A miniature Western blot assay was utilized to screen for IgG reactivity to protein species in detergent extracts of ovarian cancer tumor cells. EBV-transformed cells selected after screening were then fused with heteromyeloma fusion partner SHM-D33 resulting in efficient recovery of hybridomas secreting MAb of the desired specificity. Human MAbs which selectively react with antigens associated with ovarian cancer tumor cells were obtained.

Original languageEnglish (US)
Pages (from-to)263-273
Number of pages11
JournalJournal of Immunological Methods
Volume105
Issue number2
DOIs
StatePublished - Dec 24 1987
Externally publishedYes

Fingerprint

Lymphocyte Count
Ovarian Neoplasms
Human Herpesvirus 4
Monoclonal Antibodies
Antigens
Neoplasms
Ascites
Splenic Neoplasms
B-Lymphocytes
Hybridomas
Detergents
Immunoglobulin M
Immunoglobulin G
Lymph Nodes
Western Blotting
Antibodies
Proteins

Keywords

  • Epstein-Barr virus
  • Monoclonal antibody, human
  • Ovarian cancer-associated antigen

ASJC Scopus subject areas

  • Biotechnology
  • Immunology

Cite this

Generation of human monoclonal antibodies to cancer-associated antigens using limited numbers of patient lymphocytes. / Smith, Lloyd H; Yin, A.; Bieber, M.; Teng, N. N H.

In: Journal of Immunological Methods, Vol. 105, No. 2, 24.12.1987, p. 263-273.

Research output: Contribution to journalArticle

@article{1624baf572d74047bc102d3234c5cff8,
title = "Generation of human monoclonal antibodies to cancer-associated antigens using limited numbers of patient lymphocytes",
abstract = "A limiting dilution method for the efficient transformation by Epstein-Barr virus (EBV) of human B lymphocytes has been applied to the production of human monoclonal antibodies to ovarian cancer-associated antigens. Limited numbers (e.g., 2 × 105) of EBV-infected B lymphocytes from ovarian cancer patient spleen, lymph node, tumor, ascites and blood were successfully transformed using this method. An immunofiltration assay system was employed to identify EBV transformants secreting IgM antibody which reacted selectively with ovarian cancer patient ascites tumor cells, but not with a mixture of normal cell types. A miniature Western blot assay was utilized to screen for IgG reactivity to protein species in detergent extracts of ovarian cancer tumor cells. EBV-transformed cells selected after screening were then fused with heteromyeloma fusion partner SHM-D33 resulting in efficient recovery of hybridomas secreting MAb of the desired specificity. Human MAbs which selectively react with antigens associated with ovarian cancer tumor cells were obtained.",
keywords = "Epstein-Barr virus, Monoclonal antibody, human, Ovarian cancer-associated antigen",
author = "Smith, {Lloyd H} and A. Yin and M. Bieber and Teng, {N. N H}",
year = "1987",
month = "12",
day = "24",
doi = "10.1016/0022-1759(87)90274-2",
language = "English (US)",
volume = "105",
pages = "263--273",
journal = "Journal of Immunological Methods",
issn = "0022-1759",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Generation of human monoclonal antibodies to cancer-associated antigens using limited numbers of patient lymphocytes

AU - Smith, Lloyd H

AU - Yin, A.

AU - Bieber, M.

AU - Teng, N. N H

PY - 1987/12/24

Y1 - 1987/12/24

N2 - A limiting dilution method for the efficient transformation by Epstein-Barr virus (EBV) of human B lymphocytes has been applied to the production of human monoclonal antibodies to ovarian cancer-associated antigens. Limited numbers (e.g., 2 × 105) of EBV-infected B lymphocytes from ovarian cancer patient spleen, lymph node, tumor, ascites and blood were successfully transformed using this method. An immunofiltration assay system was employed to identify EBV transformants secreting IgM antibody which reacted selectively with ovarian cancer patient ascites tumor cells, but not with a mixture of normal cell types. A miniature Western blot assay was utilized to screen for IgG reactivity to protein species in detergent extracts of ovarian cancer tumor cells. EBV-transformed cells selected after screening were then fused with heteromyeloma fusion partner SHM-D33 resulting in efficient recovery of hybridomas secreting MAb of the desired specificity. Human MAbs which selectively react with antigens associated with ovarian cancer tumor cells were obtained.

AB - A limiting dilution method for the efficient transformation by Epstein-Barr virus (EBV) of human B lymphocytes has been applied to the production of human monoclonal antibodies to ovarian cancer-associated antigens. Limited numbers (e.g., 2 × 105) of EBV-infected B lymphocytes from ovarian cancer patient spleen, lymph node, tumor, ascites and blood were successfully transformed using this method. An immunofiltration assay system was employed to identify EBV transformants secreting IgM antibody which reacted selectively with ovarian cancer patient ascites tumor cells, but not with a mixture of normal cell types. A miniature Western blot assay was utilized to screen for IgG reactivity to protein species in detergent extracts of ovarian cancer tumor cells. EBV-transformed cells selected after screening were then fused with heteromyeloma fusion partner SHM-D33 resulting in efficient recovery of hybridomas secreting MAb of the desired specificity. Human MAbs which selectively react with antigens associated with ovarian cancer tumor cells were obtained.

KW - Epstein-Barr virus

KW - Monoclonal antibody, human

KW - Ovarian cancer-associated antigen

UR - http://www.scopus.com/inward/record.url?scp=0023546921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023546921&partnerID=8YFLogxK

U2 - 10.1016/0022-1759(87)90274-2

DO - 10.1016/0022-1759(87)90274-2

M3 - Article

C2 - 2826600

AN - SCOPUS:0023546921

VL - 105

SP - 263

EP - 273

JO - Journal of Immunological Methods

JF - Journal of Immunological Methods

SN - 0022-1759

IS - 2

ER -